Phase II Trial of the Combination of Temsirolimus and Sorafenib in Advanced Hepatocellular Carcinoma with Tumor Mutation Profiling.
Saved in:
| Title: | Phase II Trial of the Combination of Temsirolimus and Sorafenib in Advanced Hepatocellular Carcinoma with Tumor Mutation Profiling. |
|---|---|
| Authors: | Kelley RK; Helen Diller Family Comprehensive Cancer Center (HDFCCC), University of California, San Francisco (UCSF), San Francisco, California, USA., Joseph NM; Department of Pathology, University of California, San Francisco (UCSF), San Francisco, California, USA., Nimeiri HS; Robert H. Lurie Comprehensive Cancer Center, Northwestern University, Chicago, Illinois, USA., Hwang J; Helen Diller Family Comprehensive Cancer Center (HDFCCC), University of California, San Francisco (UCSF), San Francisco, California, USA., Kulik LM; Division of Hepatology, Department of Medicine, Northwestern University, Chicago, Illinois, USA., Ngo Z; Helen Diller Family Comprehensive Cancer Center (HDFCCC), University of California, San Francisco (UCSF), San Francisco, California, USA., Behr SC; Department of Radiology, University of California, San Francisco (UCSF), San Francisco, California, USA., Onodera C; Clinical Cancer Genomics Lab, UCSF Health, San Francisco, California, USA., Zhang K; Helen Diller Family Comprehensive Cancer Center (HDFCCC), University of California, San Francisco (UCSF), San Francisco, California, USA., Bocobo AG; Helen Diller Family Comprehensive Cancer Center (HDFCCC), University of California, San Francisco (UCSF), San Francisco, California, USA., Benson AB; Robert H. Lurie Comprehensive Cancer Center, Northwestern University, Chicago, Illinois, USA., Venook AP; Helen Diller Family Comprehensive Cancer Center (HDFCCC), University of California, San Francisco (UCSF), San Francisco, California, USA., Gordan JD; Helen Diller Family Comprehensive Cancer Center (HDFCCC), University of California, San Francisco (UCSF), San Francisco, California, USA. |
| Source: | Liver cancer [Liver Cancer] 2021 Sep 06; Vol. 10 (6), pp. 561-571. Date of Electronic Publication: 2021 Sep 06 (Print Publication: 2021). |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: S. Karger Country of Publication: Switzerland NLM ID: 101597993 Publication Model: eCollection Cited Medium: Print ISSN: 2235-1795 (Print) Linking ISSN: 16645553 NLM ISO Abbreviation: Liver Cancer Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Links: – Type: pdflink Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 34950179 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Phase II Trial of the Combination of Temsirolimus and Sorafenib in Advanced Hepatocellular Carcinoma with Tumor Mutation Profiling. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Kelley+RK%22">Kelley RK</searchLink>; Helen Diller Family Comprehensive Cancer Center (HDFCCC), University of California, San Francisco (UCSF), San Francisco, California, USA.<br /><searchLink fieldCode="AU" term="%22Joseph+NM%22">Joseph NM</searchLink>; Department of Pathology, University of California, San Francisco (UCSF), San Francisco, California, USA.<br /><searchLink fieldCode="AU" term="%22Nimeiri+HS%22">Nimeiri HS</searchLink>; Robert H. Lurie Comprehensive Cancer Center, Northwestern University, Chicago, Illinois, USA.<br /><searchLink fieldCode="AU" term="%22Hwang+J%22">Hwang J</searchLink>; Helen Diller Family Comprehensive Cancer Center (HDFCCC), University of California, San Francisco (UCSF), San Francisco, California, USA.<br /><searchLink fieldCode="AU" term="%22Kulik+LM%22">Kulik LM</searchLink>; Division of Hepatology, Department of Medicine, Northwestern University, Chicago, Illinois, USA.<br /><searchLink fieldCode="AU" term="%22Ngo+Z%22">Ngo Z</searchLink>; Helen Diller Family Comprehensive Cancer Center (HDFCCC), University of California, San Francisco (UCSF), San Francisco, California, USA.<br /><searchLink fieldCode="AU" term="%22Behr+SC%22">Behr SC</searchLink>; Department of Radiology, University of California, San Francisco (UCSF), San Francisco, California, USA.<br /><searchLink fieldCode="AU" term="%22Onodera+C%22">Onodera C</searchLink>; Clinical Cancer Genomics Lab, UCSF Health, San Francisco, California, USA.<br /><searchLink fieldCode="AU" term="%22Zhang+K%22">Zhang K</searchLink>; Helen Diller Family Comprehensive Cancer Center (HDFCCC), University of California, San Francisco (UCSF), San Francisco, California, USA.<br /><searchLink fieldCode="AU" term="%22Bocobo+AG%22">Bocobo AG</searchLink>; Helen Diller Family Comprehensive Cancer Center (HDFCCC), University of California, San Francisco (UCSF), San Francisco, California, USA.<br /><searchLink fieldCode="AU" term="%22Benson+AB%22">Benson AB</searchLink>; Robert H. Lurie Comprehensive Cancer Center, Northwestern University, Chicago, Illinois, USA.<br /><searchLink fieldCode="AU" term="%22Venook+AP%22">Venook AP</searchLink>; Helen Diller Family Comprehensive Cancer Center (HDFCCC), University of California, San Francisco (UCSF), San Francisco, California, USA.<br /><searchLink fieldCode="AU" term="%22Gordan+JD%22">Gordan JD</searchLink>; Helen Diller Family Comprehensive Cancer Center (HDFCCC), University of California, San Francisco (UCSF), San Francisco, California, USA. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22101597993%22">Liver cancer</searchLink> [Liver Cancer] 2021 Sep 06; Vol. 10 (6), pp. 561-571. <i>Date of Electronic Publication: </i>2021 Sep 06 (<i>Print Publication: </i>2021). – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22S%2E+Karger%22">S. Karger </searchLink><i>Country of Publication: </i>Switzerland <i>NLM ID: </i>101597993 <i>Publication Model: </i>eCollection <i>Cited Medium: </i>Print <i>ISSN: </i>2235-1795 (Print) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2216645553%22">16645553 </searchLink><i>NLM ISO Abbreviation: </i>Liver Cancer <i>Subsets: </i>PubMed not MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=34950179 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1159/000518297 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 561 Titles: – TitleFull: Phase II Trial of the Combination of Temsirolimus and Sorafenib in Advanced Hepatocellular Carcinoma with Tumor Mutation Profiling. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Kelley RK – PersonEntity: Name: NameFull: Joseph NM – PersonEntity: Name: NameFull: Nimeiri HS – PersonEntity: Name: NameFull: Hwang J – PersonEntity: Name: NameFull: Kulik LM – PersonEntity: Name: NameFull: Ngo Z – PersonEntity: Name: NameFull: Behr SC – PersonEntity: Name: NameFull: Onodera C – PersonEntity: Name: NameFull: Zhang K – PersonEntity: Name: NameFull: Bocobo AG – PersonEntity: Name: NameFull: Benson AB – PersonEntity: Name: NameFull: Venook AP – PersonEntity: Name: NameFull: Gordan JD IsPartOfRelationships: – BibEntity: Dates: – D: 06 M: 09 Text: 2021 Sep 06 Type: published Y: 2021 Identifiers: – Type: issn-print Value: 2235-1795 Numbering: – Type: volume Value: 10 – Type: issue Value: 6 Titles: – TitleFull: Liver cancer Type: main |
| ResultId | 1 |